LLY Options Show Heavy Put Skew and Bullish Setup at $900–$1000 – Here’s How to Trade the Playbook

Today’s market action on Eli Lilly (LLY) has been anything but boring. Here’s the quick overview to catch up:

• LLY is trading at $906.01, down 2.27% from yesterday’s close of $927.06
• Intraday swing has been wild, with prices ranging from $898.45 to $926.04
• Options open interest tells a story of cautious bears and bold bulls

What’s catching the eye is the options imbalance and price action pointing to a key pivot zone forming near $900–$1000. While the stock is down, the technicals and options activity suggest a potential reversal could be brewing. But not without risk — let’s break it down.

The Options Imbalance Points to a Battle at $900–$1100

Looking at the options chain, the put/call ratio for open interest is 1.22, meaning puts are more heavily positioned than calls. That’s a bearish signal on the surface. But not all is as it seems.

This Friday’s OTM calls are seeing heavy open interest at $1000 (2190 OI) and $1050 (2147 OI), while the puts are skewed toward strikes like $640 (1204 OI) and $895 (901 OI). These strikes are way out of the money, which hints at speculative positioning. The big call OI at $1000 and $1050 could mean some investors are pricing in a short-term rally or event-driven optimism.

The next Friday’s chain shows even more concentrated call interest at $1100 (3004 OI) and $1060 (1704 OI), which could indicate a longer-held bullish view. On the put side, the $400–$860 range has a lot of OI, which is a sign of extreme bearish positioning. That’s telling — the market is preparing for a wide range of outcomes.

And there’s no notable block trading to tip the scales, so it’s mostly retail and institutional positioning at this point.

No Major News, But Technicals Are Building a Case

There’s no headline news in the past 3-4 days about LLY, which means options activity is the primary driver of today’s volatility. That’s not unusual, especially with a stock like LLY, which is often in the spotlight for its drug pipelines and earnings.

However, without recent news, the market is left to interpret technical signals. The RSI at 37.53 is firmly in oversold territory, suggesting a bounce could be due. And with the 30D and 200D moving averages now converging around $965 and $898, we’re seeing a classic setup of support and resistance building.

Actionable Trades for LLY: Calls at $1000, Puts at $895

Here’s what I’d consider right now:

1. For the bullish play: Buy the LLY20260417C1000 call option. It has high open interest and a strike that sits just above the 30D MA. If LLY reclaims the $920 zone, this option could gain serious traction before next Friday’s expiry.
2. For the bearish hedge: Buy the LLY20260417P895 put option. It’s the top put in this week’s chain and could capitalize on a continuation of today’s move lower. The strike is just below the lower Bollinger Band and near the 200D support line.
3. For a stock entry: If you’re willing to swing for the fences, consider a buy near $898.50 if the stock holds above $898.45 (intraday low). The 200D MA is right there, and a rebound could push the stock back toward $914–$918, where the 30D support zone is forming.

Volatility on the Horizon — Be Ready for a Reversal

All signs point to a tight trading range forming around $900–$1000 for LLY, with the options market pricing in both bullish and bearish extremes. That’s not a sign of confusion — it’s a sign of positioning for a breakout.

If you’re trading options, the next few days are key. The $1000 and $1050 calls could see renewed interest if a catalyst emerges — be it earnings, a new drug approval, or just a shift in market sentiment. On the flip side, the $895 and $900 puts are there if things continue to fall.

The bottom line? LLY is at a crossroads. The options market is divided, but the technicals are building a case for a rebound. Play it smart — set stops, keep your position sizes tight, and watch for a reversal in real time.